StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)

Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%

Dr Reddys Laboratories operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was ₹56.76B, up 22.2% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is ₹58.88B in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026₹56.76B+22.2%
FY2025Mar 31, 2025₹46.43B+2.2%
FY2024Mar 31, 2024₹45.43B-22.8%
FY2023Mar 31, 2023₹58.88B+109.5%
FY2022Mar 31, 2022₹28.11B-21.3%
FY2021Mar 31, 2021₹35.70B+19.6%
FY2020Mar 31, 2020₹29.84B+4.0%
FY2019Mar 31, 2019₹28.70B+59.2%
FY2018Mar 31, 2018₹18.03B-16.2%
FY2017Mar 31, 2017₹21.51B-47.8%
FY2016Mar 31, 2016₹41.25B–

More Dr Reddys Laboratories figures

See a number that looks wrong?